Literature DB >> 16809415

Smokers with airway obstruction are more likely to quit smoking.

M Bednarek1, D Gorecka, J Wielgomas, M Czajkowska-Malinowska, J Regula, G Mieszko-Filipczyk, M Jasionowicz, R Bijata-Bronisz, M Lempicka-Jastrzebska, M Czajkowski, G Przybylski, J Zielinski.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD), usually caused by tobacco smoking, is one of the leading causes of morbidity and mortality. Smoking cessation at an early stage of the disease usually stops further progression. A study was undertaken to determine if diagnosis of airway obstruction was associated with subsequent success in smoking cessation, as advised by a physician.
METHODS: 4494 current smokers (57.4% men) with a history of at least 10 pack-years of smoking were recruited from 100 000 subjects screened by spirometric testing for signs of airway obstruction. At the time of screening all received simple smoking cessation advice. 1177 (26.2%) subjects had airway obstruction and were told that they had COPD and that smoking cessation would halt rapid progression of their lung disease. No pharmacological treatment was proposed. After 1 year all subjects were invited for a follow up visit. Smoking status was assessed by history and validated by exhaled carbon monoxide level.
RESULTS: Nearly 70% attended a follow up visit (n = 3077): 61% were men, mean (SD) age was 52 (10) years, mean (SD) tobacco exposure 30 (17) pack-years, and 33.3% had airway obstruction during the baseline examination. The validated smoking cessation rate in those with airway obstruction was 16.3% compared with 12.0% in those with normal spirometric parameters (p = 0.0003). After correction for age, sex, nicotine dependence, number of cigarettes smoked daily, and lung function, success in smoking cessation was predicted by lower lung function, lower nicotine dependence, and lower tobacco exposure.
CONCLUSIONS: Simple smoking cessation advice combined with spirometric testing resulted in good 1 year cessation rates, especially in subjects with airway obstruction.

Entities:  

Mesh:

Year:  2006        PMID: 16809415      PMCID: PMC2104752          DOI: 10.1136/thx.2006.059071

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  35 in total

Review 1.  Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.

Authors:  G T Ferguson; P L Enright; A S Buist; M W Higgins
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

2.  The economic burden of COPD.

Authors:  S D Sullivan; S D Ramsey; T A Lee
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

3.  Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society.

Authors:  P Tønnesen; P Paoletti; G Gustavsson; M A Russell; R Saracci; A Gulsvik; B Rijcken; U Sawe
Journal:  Eur Respir J       Date:  1999-02       Impact factor: 16.671

4.  Smoking, lung function, and mortality.

Authors:  N R Anthonisen
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group.

Authors:  R P Murray; N R Anthonisen; J E Connett; R A Wise; P G Lindgren; P G Greene; M A Nides
Journal:  J Clin Epidemiol       Date:  1998-12       Impact factor: 6.437

7.  Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men.

Authors:  M Pelkonen; H Tukiainen; M Tervahauta; I L Notkola; S L Kivelä; Y Salorinne; A Nissinen
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

8.  Characteristics of participants who stop smoking and sustain abstinence for 1 and 5 years in the Lung Health Study.

Authors:  R P Murray; L B Gerald; P G Lindgren; J E Connett; C S Rand; N R Anthonisen
Journal:  Prev Med       Date:  2000-05       Impact factor: 4.018

9.  Ongoing airway inflammation in patients with COPD who do not currently smoke.

Authors:  S R Rutgers; D S Postma; N H ten Hacken; H F Kauffman; T W van Der Mark; G H Koëter; W Timens
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

10.  Effect of general practitioners' advice against smoking.

Authors:  M A Russell; C Wilson; C Taylor; C D Baker
Journal:  Br Med J       Date:  1979-07-28
View more
  53 in total

1.  Tips for GP trainees working in respiratory medicine.

Authors:  Tim G Martindale; Katie Pink
Journal:  Br J Gen Pract       Date:  2012-02       Impact factor: 5.386

2.  Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study.

Authors:  Tuula Toljamo; Marjo Kaukonen; Pentti Nieminen; Vuokko L Kinnula
Journal:  Scand J Prim Health Care       Date:  2010-03       Impact factor: 2.581

3.  Early diagnosis of COPD.

Authors:  Nigel Masters; Catherine Tutt; Jenny Eades
Journal:  Br J Gen Pract       Date:  2006-12       Impact factor: 5.386

4.  Spirometric screening: Does it work?

Authors:  D M Mannino
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

5.  Incentives to quit smoking in primary care.

Authors:  Raphaël Bize; Jacques Cornuz
Journal:  BMJ       Date:  2008-03-06

6.  Spirometric screening for COPD: wishful thinking, not evidence.

Authors:  Patrick White
Journal:  Thorax       Date:  2007-08       Impact factor: 9.139

7.  Assessing the efficacy of spirometry for smoking cessation.

Authors:  D Kotz; C P van Schayck; M J H Huibers; G J Wesseling
Journal:  Thorax       Date:  2007-08       Impact factor: 9.139

8.  Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.

Authors:  Stefan Andreas; Thomas Hering; Stephan Mühlig; Dennis Nowak; Tobias Raupach; Heinrich Worth
Journal:  Dtsch Arztebl Int       Date:  2009-04-17       Impact factor: 5.594

9.  Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Samantha A Barry; Martin C Tammemagi; Sofiya Penek; Elisabeth C Kassan; Caroline S Dorfman; Thomas L Riley; John Commin; Kathryn L Taylor
Journal:  J Natl Cancer Inst       Date:  2012-10-26       Impact factor: 13.506

10.  Immediate and short-term impact of a brief motivational smoking intervention using a biomedical risk assessment: the Get PHIT trial.

Authors:  Jennifer B McClure; Evette Ludman; Lou Grothaus; Chester Pabiniak; Julie Richards; Amy Mohelnitzky
Journal:  Nicotine Tob Res       Date:  2009-03-18       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.